Regulatory Gemish: COVID-19’s big impacts on the FDA and beyond
Release Date:
Peter Pitts, president of the Center for Medicine in the Public Interest, on how government regulation seems like a slow but in actuality moves more quickly than understood. Hosted on Acast. See acast.com/privacy for more information.
Regulatory Gemish: COVID-19’s big impacts on the FDA and beyond